Urology Marketing Consultant & Advisor for Urologists, Urologic Surgery, Cancer & Men's Health
Urology lives in an unusual corner of medicine. A person may arrive worried about cancer, unable to urinate, passing a kidney stone, researching robotic surgery, dealing with incontinence, or trying very hard not to type a perfectly normal sexual-health question into a work laptop. I help urology practices make those very different journeys easier to find, understand, trust and act on.
- General urology, stones, BPH, cancer, robotic surgery, pelvic medicine and sexual health can create completely different demand and referral patterns inside one practice.
- Privacy matters unusually early. People often research urinary and sexual-health concerns before they are ready to talk about them with anyone.
- Local search can drive substantial outpatient demand, while oncology and advanced surgery often depend more heavily on physician reputation, referral networks and regional authority.
- Men's health deserves adult medical communication. The internet already contains enough miracle language, chest-beating and mystery supplements.
- Marketing cannot fix a six-week new-patient wait, a phone queue nobody answers or a referral process that loses records between systems.
- I work on strategy, communication, search, AI discovery, referrals, paid media, websites and growth. I am not a urologist and do not make clinical decisions.
One specialty, a surprising number of completely different business models.
- Why urology is different
- The urology service map
- Private questions and patient intent
- Six kinds of urology demand
- BPH and general urology
- Kidney stones and urgent demand
- Urologic oncology
- Robotic surgery and procedures
- Men's health and sexual medicine
- Testosterone and medical claims
- Andrology and male infertility
- Female urology and pelvic medicine
- Referrals and physician relations
- SEO, local, AI and voice discovery
- Paid media, privacy and tracking
- Website, scheduling and access
- Multi-location and platform growth
- Economics and measurement
- A hypothetical growth problem
- How I work with urology groups
- Current sources and medical context
- Urology marketing FAQs
“Urology practice” can describe five businesses hiding under one sign.
A urology group may have physicians who spend most of their time in office-based general care, surgeons whose calendars depend on hospital or ASC block time, subspecialists whose growth comes through professional referrals, and men's health services that generate direct patient demand through search. Add imaging, pathology, medication management, procedure authorization, call coverage and several locations and the practice quickly stops behaving like a simple local professional service.
That is why I keep the broad physician-marketing work on Paper Boat Media's physician and surgeon authority page and give urology its own specialist treatment here. The physician page owns general practice growth. This page owns the peculiar commercial mechanics of urinary, oncologic, surgical and sexual-health care.
The distinction matters. A campaign that fills an office schedule with lower urinary tract complaints is doing a different job from a strategy designed to increase regional referrals for complex bladder cancer. Both can be called urology marketing. They require different audiences, proof, content, access and measurement.
That sounds like a small writing point. It is actually a trust point. Patients need clinical clarity, plain language and discretion. Referring physicians need precision. Search engines need enough specificity to understand the service. An executive team needs to know which line of business deserves the next dollar. The page has to hold all four conversations without turning into a medical dictionary.
Urology demand changes with the problem, the physician and the next clinical step.
I am not grouping these services because a website menu needs tidy boxes. I separate them because search behavior, referral sources, urgency, payer dynamics, patient anxiety and procedure economics can change dramatically across the specialty.
General urology
LUTS, hematuria, recurrent UTIs, prostate concerns, urinary retention and other common problems can generate substantial local direct demand. Visibility, insurance context, physician access and practical scheduling information often matter immediately.
BPH and voiding
BPH can sit at the intersection of chronic symptoms, medication, office evaluation and procedural care. Content has to explain the condition, possible categories of care and physician expertise while stopping well short of prescribing a treatment path online.
Stone disease
Kidney stones can create acute, high-intent searches. Pain and urgency change the conversion clock. Same-day pathways, imaging access, emergency-department relationships, procedure availability and after-hours instructions can become part of the growth system.
Urologic oncology
Prostate, bladder, kidney, testicular and other genitourinary cancers involve specialist reputation, multidisciplinary care, staging, second opinions, surgery, systemic treatment relationships and regional referral patterns. The trust burden is higher and the patient research cycle can be intense.
Robotic and complex surgery
Robotic prostatectomy, partial nephrectomy, cystectomy and other procedures create interest in technology, but the robot itself should not become the entire brand. Surgeon training, case focus, program depth, hospital support and appropriate outcome evidence deserve the attention.
Men's health and andrology
Erectile dysfunction, Peyronie's disease, sexual medicine, male infertility and related care are intensely private. Direct search can be strong, while bad actors in the broader men's-health market make medical credibility especially valuable.
Female urology and pelvic medicine
Incontinence, overactive bladder, recurrent UTIs, voiding dysfunction and pelvic-health concerns deserve clear visibility. A prostate-dominated website can accidentally make women wonder whether the practice treats them at all.
Pediatric and transitional care
When pediatric urology is part of the group, the buyer and communicator often changes from patient to parent or caregiver. Referral networks, developmental context and family-centered information become more important.
Some of the most important urology searches happen before a person is comfortable saying the words out loud.
A patient can ask a browser a question they have not asked a spouse, friend or primary-care physician. That is particularly true for erectile dysfunction, urinary leakage, blood in the urine, changes in ejaculation, penile curvature, infertility, testicular concerns and symptoms people associate with cancer.
The practical implication is simple: privacy and dignity begin at the search result, not at the front desk. A page title that sounds sensational, a retargeting ad that follows somebody around the internet or a form that requests unnecessary detail can create friction before the medical relationship begins.
It is the sum of what the site asks, what technology collects, what advertising platforms receive, what staff say on the phone, where forms route, who can see messages and how confidently the organization can explain the data path.
Good content can reduce shame without making a diagnosis. It can tell somebody that a urologist commonly evaluates a problem, explain what information may be useful for an appointment, identify the physician with relevant focus and give a discreet next step. That is useful to patients, useful to voice search and useful to AI systems trying to answer a natural-language question.
I prefer direct language. A page about ED should say erectile dysfunction. A page about urinary incontinence should say urinary incontinence. Euphemisms can make a healthcare brand sound nervous about its own medicine.
Six routes can lead to the same waiting room.
A patient searches because something changed: pain, blood, leakage, frequency, difficulty urinating or another concern.
A PCP, ED, imaging study or lab result creates a new need for specialist evaluation.
A clinician already knows the category of care and needs the right urologist, location and access path.
The patient researches a treatment, surgery, technology, implant or second opinion after a recommendation.
Sexual health, fertility and pelvic symptoms often create quiet direct searches before formal referral.
Cancer follow-up, stones, chronic symptoms and post-treatment care create recurring relationships rather than one-time acquisition.
The phrase “get more urology patients” is too imprecise to fund responsibly. Which patients, for which doctors, at which locations, for which services, with how much capacity?
That question usually exposes the real project. A group may have plenty of demand but weak routing. One physician may need more general-urology volume while another has a four-month surgical backlog. A new location may need local visibility. A cancer program may need tertiary referrals. A men's health service may have direct demand but weak trust. The marketing mix should follow that reality.
A very common condition can still create a complicated patient decision.
Benign prostatic hyperplasia is a useful example of why urology pages need both depth and restraint. NIDDK describes BPH as noncancerous enlargement of the prostate and estimates that it affects 29% to 33% of men ages 65 and older. Symptoms can include frequency, urgency, nocturia, weak stream and difficulty emptying the bladder. Those symptoms can also appear in other urinary problems, which is exactly why marketing copy should explain care without pretending to sort the diagnosis from a webpage.
Source and current patient context: National Institute of Diabetes and Digestive and Kidney Diseases, Enlarged Prostate (BPH).
Commercially, BPH can support local search, physician education, procedure content and high-intent paid search where appropriate. The page structure should allow a person to understand the symptom category, the role of evaluation, treatment categories and which physicians focus on the problem. A device brand or procedure name should not swallow the entire service line unless that really is the practice's business strategy.
There is also a capacity question. If a BPH campaign produces inquiries for a physician who is booked for months, the campaign may be excellent at creating frustration. I want the demand plan attached to clinic access, testing availability, authorization realities and the procedure calendar.
Kidney-stone demand has a clock attached to it.
NIDDK estimates that about 11% of men and 6% of women in the United States experience kidney stones at least once. A stone can cause sharp pain, bleeding or urinary obstruction. That changes the commercial journey because the patient is often searching now, not building a three-month shortlist.
Source: NIDDK, Kidney Stones.
A practice advertising stone care should know what “urgent” actually means operationally. Can somebody speak with the office today? Is there same-day or next-day evaluation for appropriate patients? How are ED and urgent-care referrals handled? What happens when the patient needs imaging? Which locations have procedure access? When should a patient seek emergency care instead?
This is where a basic marketing dashboard becomes inadequate. A keyword can look profitable because calls increase, while the front desk quietly tells half of those callers that the next appointment is three weeks away. The better metric may be time to appropriate evaluation, kept visit, downstream procedure when clinically indicated and the percentage of urgent inquiries that the organization can actually serve.
Urologic oncology needs enough depth for the patient and enough precision for the referrer.
Prostate cancer alone is a very large clinical category. The American Cancer Society estimates 333,830 new prostate cancer cases and 36,320 deaths in the United States in 2026. Bladder cancer adds an estimated 84,530 new cases in 2026. Those numbers are population context, not a marketing trophy. They explain why cancer-related urology attracts a large volume of patient questions, second opinions and professional referrals.
2026 estimates: American Cancer Society prostate cancer fact sheet and Cancer Facts & Figures 2026.
The website job becomes more demanding after a cancer diagnosis. Patients may want to understand which doctor focuses on which cancer, where surgery occurs, how multidisciplinary care works, whether second opinions are available and what the next appointment process looks like. Referring physicians want subspecialty fit, access and confidence in the handoff.
Prostate screening deserves particular care. NCI notes that PSA can be elevated for reasons other than cancer and that screening remains an area where benefits, harms and individual context matter. I would avoid a blanket campaign that turns a nuanced screening conversation into “every man needs this test now.” That may generate volume while reducing medical credibility.
Screening context: National Cancer Institute, Prostate Cancer Screening.
For the patient
Explain the condition, the type of specialist, the next appointment, the location, the role of testing, the questions worth asking and the difference between evaluation and treatment. Reduce panic without minimizing seriousness.
For the referrer
Make subspecialty scope, physician access, records transfer, urgent pathways, hospital affiliation and communication expectations easy to understand. Referral marketing is partly a promise about the handoff.
A robot in the hero image does not explain surgical expertise.
Robotic surgery can be an important part of urologic care and a meaningful research topic for patients. It can also become a lazy marketing shortcut. Practices sometimes give the technology more personality than the surgeon: giant glowing robot, three bullets about small incisions, call now.
I would rather explain the program. Which surgeons use the platform? Which procedures do they perform? What is their training and focus? Where does surgery occur? How does the patient get from consultation to surgery? What does the hospital or cancer program contribute? Which outcome claims can actually be supported?
The same discipline applies to lasers, implants, minimally invasive BPH therapies and diagnostic technologies. Device recognition can generate demand, but the physician and care program should still own the medical relationship. Technology changes. Reputational authority has a longer shelf life.
Before publishing “faster,” “safer,” “better,” “less pain,” “best,” “leading” or similar language, ask what evidence supports the exact claim, for which procedure, compared with what, and whether the organization is comfortable defending it outside a marketing meeting.
That level of review is especially useful for hospital and health-system service lines, where the urologist's brand and the hospital's program brand may share the same surgical journey.
The internet has plenty of confidence. Medical credibility is the scarce asset.
Erectile dysfunction is common. NIDDK says research suggests 30 million to 50 million men in the United States have ED, and it emphasizes that ED can have multiple causes involving blood vessels, nerves, hormones, medicines, emotional health and other conditions. That complexity is exactly why a legitimate urology practice should resist the urge to market ED like a supplement funnel.
Source: NIDDK, Erectile Dysfunction.
A patient may already have been exposed to miracle claims, anonymous telehealth ads, social posts, “natural” enhancement products and masculinity language designed to make insecurity convert. A medical practice can be the adult in the room. Explain that evaluation matters. Introduce the clinicians. Describe treatment categories carefully. Make privacy clear. Give people a respectful path to ask questions.
There is room for good humor in healthcare. There is much less room for humiliation. I would rather write a page that makes somebody think, “Fine, I can talk to this doctor,” than one that earns a cheap laugh and loses the appointment.
Men's health copy has to keep up with the medicine instead of aging quietly in WordPress.
Testosterone is a good example. FDA changed class-wide labeling in 2025 after reviewing cardiovascular and blood-pressure data, then requested additional testosterone prescribing-information updates in June 2026, including changes involving the previous limitation of use for age-related hypogonadism and safety information around prostate cancer and BPH.
Current FDA context: FDA Testosterone Information.
I am not using that update to make a treatment recommendation. I am using it to make a marketing point: regulated medical copy needs dates, owners and review. A clinic page written around a 2022 regulatory assumption can still rank beautifully in 2026 while being medically stale.
For a urology or men's health program, I would separate several things that sloppy marketing often blends together: symptoms, diagnosis, laboratory evaluation, approved treatment, physician judgment, wellness language and consumer-product claims. “Low T” may be a familiar search phrase, but the clinical pathway is more serious than the phrase makes it sound.
That is also why I avoid promising that a specific therapy will restore youth, masculinity, energy, sexual performance or body composition for everyone. The marketing does not need to be timid. It needs to be supportable.
Male fertility belongs in urology without stealing the fertility clinic's entire conversation.
Urologists can play a central role in male-factor infertility, sexual function, semen abnormalities, varicocele evaluation, hormonal questions and surgical sperm retrieval. Those services deserve clear pages because patients and couples often do not know which specialist owns which part of the problem.
The boundary matters on Paper Boat Media too. The dedicated fertility clinic, IVF and reproductive medicine authority page owns the broader clinic journey: reproductive endocrinology, IVF, donor programs, gestational carriers, fertility preservation and family-building strategy. This urology page owns the urologic and andrology side of male reproductive health.
That separation gives both resources a stronger job. It also creates a natural handoff between them, because real patients do not care which silo the marketing team put on the org chart. They care about getting from “there may be a male factor” to the right clinician without repeating the same story five times.
A prostate-heavy brand can accidentally make the practice look closed to women.
Urology is commonly associated with men's health because of prostate and male reproductive care. That association can become a website problem when the practice also treats women with urinary incontinence, recurrent UTIs, overactive bladder, voiding dysfunction, stones or other urinary conditions.
The fix is not a pink navigation tab labeled “women.” The fix is a clear clinical map: conditions, services, physicians, pelvic-health focus, diagnostic pathways, locations and the relationship to urogynecology when that specialty is relevant.
Search behavior can be symptom-led here too. People ask conversational questions about leaking when coughing, waking to urinate, recurrent infections and urgency. Useful pages can explain that these symptoms deserve medical evaluation, identify the relevant specialist and give a practical next step.
That same clarity supports AI and voice discovery because the content answers a real question in language a patient would actually use. The goal is to be understandable without being reductive.
A referral is partly a clinical decision and partly a confidence decision about the handoff.
Primary-care physicians, emergency departments, oncologists, nephrologists, gynecologists, fertility specialists and other clinicians may all refer into urology. Their questions are practical: Who handles this? How quickly can the patient be seen? Do I need imaging first? Which office? Who takes the difficult case? Will I know what happened?
A referral strategy can include physician outreach, subspecialty profiles, referral guides, urgent pathways, service updates, educational content, geographic coverage and better communication after the visit. None of that requires turning physicians into salespeople.
The marketing team's job is to remove ambiguity around capability and access. If the practice has one surgeon who focuses heavily on bladder cancer, another on stones and another on reconstructive urology, make that legible to the professional community.
The referral promise
- Right physician for the problem
- Clear urgency pathway
- Fast enough appointment access
- Simple records transfer
- Known hospital and facility context
- Communication back to the referrer
- Respectful patient experience
- Confidence in subspecialty depth
The practice may know how many web forms arrived but have no clean view of delayed referrals, lost faxes, incomplete records, wrong-physician scheduling or patients who gave up after being transferred three times. Those are growth problems too.
Urology search is local, conversational, clinical and occasionally very specific at 2:13 a.m.
Organic strategy has to accommodate several layers at once. A person may search “urologist near me,” “blood in urine doctor,” “BPH treatment,” a specific robot-assisted procedure, a physician's name or an entire question about symptoms. A referrer may search for a subspecialist. An AI assistant may synthesize multiple sources before the patient ever sees the practice website.
I connect those behaviors through AI search optimization, GEO, AEO and organic search strategy. The durable work is less glamorous than pretending there is a secret ChatGPT button. It is accurate service pages, strong physician entities, clean location relationships, useful answers, clear internal links, technical accessibility, credible sources and enough original expertise to be worth retrieving.
Voice search makes plain language especially valuable. People do not usually speak like a keyword spreadsheet. They ask, “What kind of doctor treats an enlarged prostate?” “Can a urologist treat ED?” “Who treats recurrent kidney stones?” “Should I see a urologist for blood in my urine?” A practice page should be able to answer the category question directly while still telling the person when to seek qualified care.
Local discovery
Locations, Google Business Profiles, physician availability, reviews, insurance context, service coverage, driving radius and accurate local pages are especially important for general urology.
Regional authority
Complex oncology, reconstruction and advanced surgery may attract patients and referrals from a wider area. Subspecialty reputation and professional relationships become more important than proximity alone.
For the broader healthcare relationship, this page sits under the completed Healthcare & Medical authority hub. That parent resource owns the sector-wide picture; this specialist page can go deep without forcing the hub to carry every prostate, bladder, stone and sexual-health query itself.
Urology is exactly the kind of category where “just turn on remarketing” deserves another question.
Google's current personalized-advertising policy treats health as a sensitive interest category. Its examples explicitly include sexual health, genital health, urinary health and invasive medical procedures. Google restricts advertiser-curated audiences such as Customer Match and first-party data segments for sensitive-interest promotion, while allowing some predefined audiences under the policy's rules.
Current platform policy: Google Ads, Health in personalized advertising. Google also published a June 2026 clarification affecting Demand Gen and Discovery serving implications for sensitive-interest categories.
That does not mean paid search is useless. Search can be powerful for high-intent urology demand because the person is actively asking for the service. It does mean campaign design, audience use, conversion tracking and landing pages should be reviewed with much more care than a plumber's campaign.
HIPAA deserves the same specificity. HHS continues to publish guidance on tracking technologies used by HIPAA-regulated entities, while acknowledging that a federal court vacated part of its prior interpretation involving IP addresses and visits to certain unauthenticated public webpages. I would rather trace the actual data flow than make a sweeping claim that every pixel is illegal or every analytics tool is safe.
Current HHS context: Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates.
The best urology landing page in the state cannot answer a phone nobody picks up.
Healthcare marketing becomes much more interesting when the measurement continues past the form submission.
| Stage | What the person needs | Common friction |
|---|---|---|
| Discover | Correct specialty, service and location | Generic pages, weak local visibility, unclear physician focus |
| Understand | Plain explanation and trustworthy clinician context | Medical jargon, device-first marketing, thin physician bios |
| Contact | Private, practical way to request care | Long forms, unclear phone routes, risky tracking, poor mobile UX |
| Schedule | Appropriate physician and realistic timing | Wrong-provider booking, delays, insurance confusion, transfer loops |
| Prepare | Instructions, records, testing and expectations | Missing records, duplicate work, unclear prep, authorization surprises |
| Continue | Follow-up, surveillance or next procedure | Weak handoffs, missed recalls, disconnected facilities or systems |
Every row can change the economics of acquisition. If 100 high-intent calls produce 24 appropriate appointments because routing is poor, buying 30% more traffic is the expensive solution to the wrong problem.
That is why I care about call data, scheduling lag, physician capacity, abandoned forms, appointment type, referral source and downstream utilization where the organization can measure it appropriately. Marketing should be connected to the operating system around the patient, even when the marketing team does not own that operating system.
Scale creates leverage, then immediately asks whether anyone can find the right doctor.
Regional urology groups, MSOs and private-equity-backed platforms can gain substantial advantages from shared technology, centralized operations, broader recruiting, stronger payer negotiation and cross-market expertise. They can also inherit websites that read like a family reunion directory after six acquisitions.
The growth questions become architectural and operational: Which brand leads? Which acquired names still carry local equity? Which physician works where? Which locations offer which procedures? Does central scheduling understand subspecialties? Are location pages distinct enough to be useful? Can leadership compare performance across markets without forcing every office into the same target?
I approach expansion as a market portfolio. One city may need general-urology access. Another may support a cancer center. A third may have an underused ASC. A fourth may need physician recruitment before demand generation. The website, media plan and referral strategy should reflect those differences.
For healthcare organizations that sit across provider, service and enterprise models, the broader healthcare services marketing and advisory resource provides another useful connection.
A full schedule is not automatically the same thing as a healthy growth strategy.
Urology groups can contain very different economic engines. Office visits, diagnostics, surgery, ancillaries, recurring surveillance, self-pay services and facility relationships can contribute differently to growth. Payer mix, physician productivity, referral dependence and capacity complicate the picture further.
I do not need every client to hand me a perfect contribution-margin model on day one. I do want the marketing conversation to move beyond clicks. If leadership says stone procedures, robotic oncology and a new satellite office are priorities, the reporting should eventually tell something useful about those priorities.
| Signal | What it can tell me | Why context matters |
|---|---|---|
| Qualified calls | Demand quality by service and source | A call about a service the practice does not offer is still a conversion in many ad dashboards. |
| Kept new-patient visits | Whether inquiries become actual access | Scheduling delay and insurance fit can change the result. |
| Referral mix | Professional sources, leakage and geographic strength | High-value subspecialty growth may depend on a small number of relationships. |
| Service-line mix | Which areas are actually growing | Volume can rise while the priority service stays flat. |
| Physician capacity | Where demand can be absorbed | The most visible doctor may be the least available doctor. |
| Downstream value | How acquisition connects to procedures or ongoing care | Use appropriate privacy, clinical and financial governance. |
Suppose a nine-urologist group says it needs more patients. I would probably make that sentence smaller before making the campaign bigger.
Imagine a fictional nine-urologist group with three offices. One partner has a strong robotic oncology reputation and limited clinic availability. Two physicians want to grow BPH procedures. A newer urologist has substantial general-urology capacity. The stone line gets emergency referrals but the office has no reliable same-day pathway. Men's health produces web inquiries, yet staff dislike discussing ED on the phone and transfer callers inconsistently.
The wrong response is one giant “urologist near me” campaign across the whole market.
I would first separate the business questions. The general-urology physician needs local visibility and appointment access. The BPH physicians need condition and procedure education plus a conversion path that matches evaluation capacity. The oncology surgeon needs regional referral authority and a page that explains expertise without making unsupported outcome claims. The stone program needs an operational decision before more urgent demand. Men's health needs staff scripting, privacy review and a normal adult intake experience.
Then I would look at search visibility, local profiles, physician entities, website routing, calls, referrals, payer fit and market competition. Some work might be shared across the entire practice, such as technical site cleanup, analytics and brand credibility. Other work should remain service-specific.
That is what I mean by strategy. It is not a prettier spreadsheet of tactics. It is deciding which problem deserves to be solved first and making sure the solution does not create three new ones.
It illustrates the type of diagnostic thinking I use. It is not presented as a client, a case study or a claimed result.
I want to understand the practice before prescribing the marketing.
I am comfortable discussing search, AI, PPC, websites, content, analytics, physician reputation, referrals and conversion. I just do not assume the channel is the diagnosis.
My first questions are usually about the organization: physicians, subspecialties, locations, hospitals, ASCs, service priorities, payer mix, current demand, referral patterns, access, call handling, technology, reputation and what leadership wants to be different a year from now.
From there I can work as a consultant, senior advisor, fractional CMO, writer, analyst or hands-on strategic partner. Some urology groups need a full digital growth program. Others need an experienced person to identify why a service line is underperforming, rebuild the argument and coordinate the right specialists.
I bring the same scientific curiosity to the work that I bring to other technical sectors. I will read the clinical source, ask physicians to correct what needs correcting and keep marketing claims inside the evidence. That does not make me a clinician. It makes me a strategist who respects the cost of being sloppy around medicine.
For a broader view of how this fits into healthcare, see the Healthcare & Medical industry hub, the physician and surgeon marketing page, hospital and health-system strategy, and laboratory marketing where diagnostics and pathology create adjacent commercial relationships.
The sources I would rather check than vaguely remember.
Urology includes areas where screening guidance, drug labeling, device use, privacy interpretation and advertising rules can move. I treat dated medical and regulatory statements as dated statements, not permanent wallpaper.
- American Cancer Society, 2026 Prostate Cancer Fact Sheet
- American Cancer Society, Cancer Facts & Figures 2026
- National Cancer Institute, Prostate Cancer Screening
- NIDDK, Benign Prostatic Hyperplasia
- NIDDK, Erectile Dysfunction
- NIDDK, Kidney Stones
- FDA, Testosterone Information
- FDA, Sexual Enhancement Product Notifications
- Google Ads, Health in Personalized Advertising
- HHS OCR, Online Tracking Technologies Guidance
Those links are provided for current context. A urology organization should still use its own clinical, legal, privacy and compliance review appropriate to its services, jurisdictions, technologies and claims.
Urology marketing questions that deserve better answers than “run more ads.”
What does a urology marketing consultant do?
A urology marketing consultant connects the practice's business goals with the way patients and referring clinicians actually find, evaluate and access urologic care. I can work across positioning, websites, organic search, AI discovery, local visibility, paid media, referrals, reputation, patient education, measurement and growth strategy while keeping clinical decisions with qualified medical professionals.
How is urology marketing different from general physician marketing?
Urology combines urgent symptoms, cancer, chronic disease, surgery, intimate health questions, diagnostic testing and elective or self-pay services. That mix changes search behavior, referral dependence, privacy expectations, conversion paths and the economics of different service lines. The broad physician page covers physician-practice growth generally; this page focuses on the commercial and communication problems specific to urology.
Do you work with general urology practices?
Yes. General urology can include lower urinary tract symptoms, BPH, stone disease, hematuria, UTIs, incontinence, prostate concerns and a wide range of office and procedural care. The strategy should reflect the practice's actual physician mix, locations, payer environment, referral network and capacity rather than forcing every group into the same specialty template.
Can you help market urologic oncology and robotic surgery programs?
Yes. Urologic oncology and robotic surgery often require deeper physician-authority content, condition and procedure education, professional referral support, hospital relationships and careful explanation of access. I do not make claims about clinical superiority that the organization cannot substantiate, and I do not treat the presence of robotic technology as proof of better outcomes.
Can you help with prostate cancer marketing?
Yes, on the business, communication and discovery side. Prostate cancer content has to respect uncertainty around screening, diagnosis, staging and treatment choices. I can help make the practice's expertise, physicians, services and referral pathways clearer while qualified clinicians remain responsible for clinical recommendations and medical claims.
Can you market BPH and enlarged-prostate services?
Yes. BPH is a major urology demand category with symptoms that can affect sleep, daily routines and quality of life. A strong strategy can clarify evaluation, treatment categories, physician expertise, locations and next steps without implying that a website can determine which treatment is appropriate for a particular patient.
Can you help a kidney stone program grow?
Yes. Stone disease has a different demand pattern from many chronic urology services because urgency, pain, imaging, emergency-department handoffs, same-day access and procedural capacity can matter. Marketing should account for how quickly a practice can actually evaluate appropriate patients before spending aggressively to create more demand.
Do you work with men's health and sexual medicine?
Yes, when the services are part of legitimate healthcare delivered by appropriately qualified clinicians. That can include erectile dysfunction, andrology, Peyronie's disease, male infertility and related urologic care. I treat these subjects as healthcare, use adult language without sensationalism, and pay close attention to advertising restrictions, privacy and supportable claims.
Can you market testosterone therapy or low-testosterone services?
Potentially, but the claims, prescribing context, current FDA labeling, clinical review and advertising rules need careful attention. Testosterone is an area where regulatory and medical guidance can change, so I would rather verify current authoritative information than recycle old claims from another clinic's website.
Do you market male enhancement supplements?
That is a different category from a urology practice, and I would not blur the two. FDA continues to publish warnings about sexual-enhancement products containing undeclared drug ingredients. A medical urology brand should create distance from the exaggerated promises and vague ingredient stories that are common in that market.
How do you approach erectile-dysfunction marketing without making it embarrassing?
Use clear, normal language. Erectile dysfunction is a health issue that can involve vascular, neurologic, hormonal, medication, psychological and other factors. The website should make it easy to understand who evaluates ED, what the consultation may involve and how to request care privately. Cheap jokes and macho promises create attention, but they can destroy medical trust.
Do you help with male infertility and andrology?
Yes, with an important boundary. Urologic evaluation, male-factor infertility, andrology and related procedures fit naturally here. IVF, reproductive endocrinology, donor programs and broader fertility-clinic growth belong to Paper Boat Media's dedicated fertility authority page. Cross-linking those resources is more useful than making two pages compete for the same family-building intent.
Is nephrology part of this urology page?
No. Urology and nephrology overlap around the kidneys, but they are different specialties. This page focuses on urologic and surgical urinary-tract care. Medical kidney disease, chronic kidney disease management, dialysis and nephrology referral strategy remain outside this page's primary ownership.
Can you help market female urology, incontinence and pelvic medicine?
Yes. Urology is not a men's-only specialty. Practices may treat urinary incontinence, recurrent UTIs, overactive bladder, voiding dysfunction, pelvic-floor problems and other conditions affecting women. The site should make those services visible instead of allowing a prostate-heavy brand to accidentally tell half the market that the practice is not for them.
Does local SEO matter for urologists?
Very much for general and outpatient urology. Patients commonly search by condition, physician, procedure, insurance context and location. Accurate location pages, physician profiles, Google Business Profile management, reviews, clear service information and a website that maps services to the correct offices can all support local discovery.
How should a urology practice approach AI search and voice search?
Answer the questions patients and referral sources actually ask in complete, useful language. Explain what the practice treats, which physicians focus on which problems, where care is available, how referrals work and what someone should do next. AI systems decide what they retrieve and summarize, so the durable goal is to become a clearer and more credible source rather than chase a guaranteed citation trick.
Can paid search work for urology?
Yes, especially for selected high-intent services, but it needs more judgment than ordinary local advertising. Google treats health, sexual health, urinary health and invasive procedures as sensitive interests for personalized advertising, which affects targeting options. Campaign structure, landing pages, privacy, call handling and service capacity all matter.
Can a urology practice use remarketing?
Healthcare remarketing and audience use require careful review of the platform's current rules, the organization's privacy obligations and the data being collected. Google restricts advertiser-curated audiences for sensitive health interests. I would audit the actual campaign, tags, consent approach and data flow instead of assuming a generic remarketing setup is appropriate.
Does HIPAA prohibit analytics on every urology webpage?
No blanket statement like that is accurate. HHS guidance addresses how HIPAA-regulated entities use online tracking technologies, and a 2024 federal court order vacated part of HHS's prior unauthenticated-webpage interpretation. The right answer depends on the data, page, technology, disclosures, relationships and applicable law. Privacy review should be specific rather than theatrical.
Can you help improve physician referrals to a urology practice?
Yes. Referral growth can involve subspecialty clarity, physician access, scheduling, communication, geographic coverage, hospital relationships, useful professional content and confidence in the patient handoff. A referral program should make it easier for a clinician to know who handles the case and easier for the patient to get where the referral intended.
What should a urology practice measure besides leads?
I would look at appropriate new-patient appointments, kept consultations, referral sources, service-line mix, physician and location capacity, procedure progression where appropriate, call performance, scheduling delay, payer mix, acquisition cost and downstream value. A large lead count can hide a small business result if the wrong patients arrive or cannot get scheduled.
Do you work with multi-location or private-equity-backed urology groups?
Yes. Larger groups introduce questions around local brands, acquired practices, physician identity, duplicate content, location strategy, centralized scheduling, data consistency and which service lines each market should actually grow. Scale creates useful leverage, but it can also create a website with forty physician pages and no clear answer to a patient's first question.
Are you a physician or urologist?
No. I am a marketing and growth strategist, writer, analyst and advisor. I can understand technical and scientific material, ask detailed questions and work comfortably with physicians and healthcare executives, but I do not diagnose patients, recommend treatment or present myself as a clinical authority.
How would you start with a urology group that says it needs more patients?
I would first determine which patients, which physicians, which locations and which services actually have capacity and economic priority. Then I would trace the current journey from discovery or referral through scheduling and care. Sometimes the answer is more demand. Sometimes the fastest growth opportunity is fixing access, routing, service visibility or referral friction before buying another click.
Can Paper Boat Media support both strategy and execution?
Yes. I can work as a senior advisor, marketing consultant, fractional CMO or hands-on strategic partner depending on the situation. The useful scope may include positioning, writing, organic search, AI discovery, websites, paid media, analytics, referral strategy, content, conversion and coordination with internal teams or outside specialists.
Bring me the urology problem before deciding which marketing tool is supposed to fix it.
Maybe the practice needs more appropriate patients. Maybe the oncology program needs stronger regional referrals. Maybe men's health gets traffic and weak conversion. Maybe three acquisitions produced five brands, nine phone numbers and one very confused website. Tell me what is happening and what you want to happen instead.
Medical and regulatory disclosure: This page discusses marketing, communication, search, privacy and business strategy for healthcare organizations. It is not medical, legal or compliance advice. Dr. Robert Urban is not a physician or urologist. Clinical claims and patient-facing medical content should be reviewed by appropriately qualified professionals, and privacy, advertising and regulatory requirements should be evaluated for the organization's actual facts and jurisdiction.